Table 1.
HD (n = 451) | PD (n = 237) | p | |
---|---|---|---|
Age (years) | 54 (14) | 51 (14) | 0,004 |
Sex (man) | 272 (60,3) | 137 (57,8) | 0,567 |
Smoker | 250 (55,4) | 135 (57,0) | 0,381 |
Diabetes | 107 (23,7) | 47 (19,8) | 0,143 |
Hypertension | 406 (90,0) | 229 (96,6) | 0,001 |
Dyslipidemia | 214 (47,5) | 153 (64,6) | 0,000 |
Plaque presence at baseline | 325 (72,1) | 156 (65,8) | 0,054 |
BMI (kg/m2) | 26,3 (5,0) | 26,7 (4,8) | 0,341 |
SBP (mmHg) | 136 (23) | 144 (24) | 0,000 |
Time on dialysis (months) | 33 (43) | 20 (19) | 0,000 |
Total cholesterol (mg/dL) | 156 (39) | 180 (43) | 0,000 |
HDL cholesterol (mg/dL) | 46 (16) | 49 (15) | 0,016 |
LDL cholesterol (mg/dL) | 84 (32) | 104 (34) | 0,000 |
Triglycerides (mg/dL) | 141 (81) | 137 (66) | 0,498 |
Glucose (mg/dL) | 103 (40) | 101 (37) | 0,526 |
Hematocrite (%) | 35,7 (4,3) | 36,6 (4,4) | 0,013 |
Calcium (mg/dL) | 9,0 (0,7) | 9,2 (0,7) | 0,005 |
Phosphate (mg/dL) | 4,8 (1,4) | 5,1 (1,2) | 0,008 |
Uric acid (mg/dL) | 6,1 (1,4) | 6,0 (1,2) | 0,22 |
iPTH (pg/mL) | 309 (281) | 277 (255) | 0,164 |
Sodium (mEq/L) | 139 (3) | 139 (3) | 0,036 |
Potassium (mEq/L) | 5,1 (0,8) | 4,5 (0,6) | 0,000 |
usCRP (mg/L) | 5,6 (10,7) | 6,1 (13,9) | 0,624 |
25OH vitamin D (ng/mL) | 16,4 (8,3) | 12,8 (5,5) | 0,000 |
1,25(OH)2 vitamin D (pg/mL) | 8,6 (5,1) | 7,7 (4,8) | 0,039 |
Treatment with Calcium-containing P binders | 186 (41,2) | 119 (50,2) | 0.015 |
Total Kt/V | 1,56 (0,39) | 2,52 (0,63)∗ | NC |
Calcium content in dialysis fluid | 0.001 | ||
2.5 mEq/L | 182 (41,9) | 72 (35.8) | |
3 mEq/L | 221 (50,9) | NA | |
3,5 mEq/L | 31 (7,1) | 129 (64.2) |
Quantitative data are shown as means (SD). Qualitative data are shown as number (%). HD, Hemodialysis; PD, Peritoneal Dialysis; BMI, Body mass index; SBP, Systolic blood pressure; iPTH, Intact parathyroid hormone; usCRP, Ultra-sensitive C reactive protein; NA, Not available. The concentration of 3 mEq/L is not available for PD dialysis fluid. NC, non comparable; ∗weekly Kt/V.